Panobinostat and Multiple Myeloma in 2018. Oncologist. 2018 05; 23(5):516-517.
Panobinostat and Multiple Myeloma in 2018.
Mundschenk MB, Odom EB, Ghosh TD, Kleiber GM, Yee A, Patel KB, Mackinnon SE, Tenenbaum MM, Buck DW
Are Residents Prepared for Surgical Cases? Implications in Patient Safety and Education. J Surg Educ. 2018 Mar - Apr; 75(2):403-408.
Are Residents Prepared for Surgical Cases? Implications in Patient Safety and Education.
O'Donnell EK, Laubach JP, Yee AJ, Chen T, Huff CA, Basile FG, Wade PM, Paba-Prada CE, Ghobrial IM, Schlossman RL, Burke JN, Harrington CC, Lively KJ, Lyons HF, Munshi NC, Anderson KC, Trippa L, Richardson PG, Raje NS
A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant-ineligible multiple myeloma. Br J Haematol. 2018 07; 182(2):222-230.
A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant-ineligible multiple myeloma.
Guo G, Raje NS, Seifer C, Kloeber J, Isenhart R, Ha G, Yee AJ, O'Donnell EK, Tai YT, Richardson PG, Bianchi G, Laubach JP, Warren D, Gemme E, Voisine J, Frede J, Kokkalis A, Yun H, Dimitrova V, Vijaykumar T, Meyerson M, Munshi NC, Anderson KC, Knoechel B, Lohr JG
Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing. Leukemia. 2018 08; 32(8):1838-1841.
Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing.
Yee A, Coombs DM, Hildebrandt S, Seidelman WE, Coert JH, Mackinnon SE
Nerve Surgeons' Assessment of the Role of Eduard Pernkopf's Atlas of Topographic and Applied Human Anatomy in Surgical Practice. Neurosurgery. 2019 02 01; 84(2):491-498.
Nerve Surgeons' Assessment of the Role of Eduard Pernkopf's Atlas of Topographic and Applied Human Anatomy in Surgical Practice.
Important Details in Performing and Interpreting the Scratch Collapse Test. Plast Reconstr Surg. 2018 02; 141(2):399-407.
Important Details in Performing and Interpreting the Scratch Collapse Test.
CT screening for lung cancer. N Engl J Med. 2007 Feb 15; 356(7):744-5; author reply 746-7.
In Reply: Nerve Surgeons' Assessment of the Role of Eduard Pernkopf's Atlas of Topographic and Applied Human Anatomy in Surgical Practice. Neurosurgery. 2018 10 01; 83(4):E189.
In Reply: Nerve Surgeons' Assessment of the Role of Eduard Pernkopf's Atlas of Topographic and Applied Human Anatomy in Surgical Practice.
Treon SP, Gustine J, Meid K, Yang G, Xu L, Liu X, Demos M, Kofides A, Tsakmaklis N, Chen JG, Munshi M, Chan G, Dubeau T, Raje N, Yee A, O'Donnell E, Hunter ZR, Castillo JJ
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström Macroglobulinemia. J Clin Oncol. 2018 09 20; 36(27):2755-2761.
Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström Macroglobulinemia.
Yee A, Oleskie AN, Dosey AM, Kretz CA, Gildersleeve RD, Dutta S, Su M, Ginsburg D, Skiniotis G
Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII. Blood. 2015 Aug 20; 126(8):939-42.
Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII.
Nooka AK, Wang ML, Yee AJ, Kaufman JL, Bae J, Peterkin D, Richardson PG, Raje NS
Assessment of Safety and Immunogenicity of PVX-410 Vaccine With or Without Lenalidomide in Patients With Smoldering Multiple Myeloma: A Nonrandomized Clinical Trial. JAMA Oncol. 2018 12 01; 4(12):e183267.
Assessment of Safety and Immunogenicity of PVX-410 Vaccine With or Without Lenalidomide in Patients With Smoldering Multiple Myeloma: A Nonrandomized Clinical Trial.
Yee A, Gildersleeve RD, Gu S, Kretz CA, McGee BM, Carr KM, Pipe SW, Ginsburg D
A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice. Blood. 2014 Jul 17; 124(3):445-52.
A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice.
Desch KC, Kretz C, Yee A, Gildersleeve R, Metzger K, Agrawal N, Cheng J, Ginsburg D
Probing ADAMTS13 substrate specificity using phage display. PLoS One. 2015; 10(4):e0122931.
Probing ADAMTS13 substrate specificity using phage display.
Simeone FJ, Harvey JP, Yee AJ, O'Donnell EK, Raje NS, Torriani M, Bredella MA
Value of low-dose whole-body CT in the management of patients with multiple myeloma and precursor states. Skeletal Radiol. 2019 May; 48(5):773-779.
Value of low-dose whole-body CT in the management of patients with multiple myeloma and precursor states.
Yee A, Zubovic E, Yu J, Ray S, Hildebrandt S, Seidelman WE, Polak RJA, Grodin MA, Coert JH, Brown D, Kodner IJ, Mackinnon SE
Ethical considerations in the use of Pernkopf's Atlas of Anatomy: A surgical case study. Surgery. 2019 05; 165(5):860-867.
Ethical considerations in the use of Pernkopf's Atlas of Anatomy: A surgical case study.
Laubach JP, Liu CJ, Raje NS, Yee AJ, Armand P, Schlossman RL, Rosenblatt J, Hedlund J, Martin M, Reynolds C, Shain KH, Zackon I, Stampleman L, Henrick P, Rivotto B, Hornburg KTV, Dumke HJ, Chuma S, Savell A, Handisides DR, Kroll S, Anderson KC, Richardson PG, Ghobrial IM
Clinical cancer research : an official journal of the American Association for Cancer Research
A Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma. Clin Cancer Res. 2019 01 15; 25(2):478-486.
A Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma.
Yee A, Hildebrandt S, Seidelman WE, Mackinnon SE
Clinical orthopaedics and related research
Letter to the Editor: Nazi Medicine-Part 2: The Downfall of a Profession and Pernkopf's Anatomy Atlas. Clin Orthop Relat Res. 2018 12; 476(12):2465-2466.
Letter to the Editor: Nazi Medicine-Part 2: The Downfall of a Profession and Pernkopf's Anatomy Atlas.
Waack U, Warnock M, Yee A, Huttinger Z, Smith S, Kumar A, Deroux A, Ginsburg D, Mobley HLT, Lawrence DA, Sandkvist M
CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII. mBio. 2018 12 18; 9(6).
CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII.
Supraclavicular Approach to the Brachial Plexus: How I Teach It. Ann Thorac Surg. 2019 02; 107(2):331-334.
Supraclavicular Approach to the Brachial Plexus: How I Teach It.
Effects of coffee and napping on nighttime highway driving. Ann Intern Med. 2007 Feb 06; 146(3):229; author reply 229.
Effects of coffee and napping on nighttime highway driving.
Ehman EC, El-Sady MS, Kijewski MF, Khor YM, Jacob S, Ruberg FL, Sanchorawala V, Landau H, Yee AJ, Bianchi G, Di Carli MF, Falk RH, Hyun H, Dorbala S
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET/CT. J Nucl Med. 2019 09; 60(9):1234-1239.
Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET/CT.
Shah N, Rosales I, Smith RN, Berchuck JE, Yee AJ, Tolkoff-Rubin N
When acute kidney injury in the intensive care unit is not acute tubular necrosis: A case report of ?-light chain crystalline tubulopathy?. Clin Nephrol. 2019 May; 91(5):311-316.
When acute kidney injury in the intensive care unit is not acute tubular necrosis: A case report of ?-light chain crystalline tubulopathy?.
Kurt J. Isselbacher Professor of Medicine in the Field of Gastroenterology
Chari A, Vogl DT, Gavriatopoulou M, Nooka AK, Yee AJ, Huff CA, Moreau P, Dingli D, Cole C, Lonial S, Dimopoulos M, Stewart AK, Richter J, Vij R, Tuchman S, Raab MS, Weisel KC, Delforge M, Cornell RF, Kaminetzky D, Hoffman JE, Costa LJ, Parker TL, Levy M, Schreder M, Meuleman N, Frenzel L, Mohty M, Choquet S, Schiller G, Comenzo RL, Engelhardt M, Illmer T, Vlummens P, Doyen C, Facon T, Karlin L, Perrot A, Podar K, Kauffman MG, Shacham S, Li L, Tang S, Picklesimer C, Saint-Martin JR, Crochiere M, Chang H, Parekh S, Landesman Y, Shah J, Richardson PG, Jagannath S
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma. N Engl J Med. 2019 08 22; 381(8):727-738.
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.
Abramson JS, Irwin KE, Frigault MJ, Dietrich J, McGree B, Jordan JT, Yee AJ, Chen YB, Raje NS, Barnes JA, Davis B
Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma. Cancer. 2019 Nov 01; 125(21):3692-3698.
Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma.
Domeshek LF, Novak CB, Patterson JMM, Hasak JM, Yee A, Kahn LC, Mackinnon SE
Plastic and reconstructive surgery. Global open
Nerve Transfers-A Paradigm Shift in the Reconstructive Ladder. Plast Reconstr Surg Glob Open. 2019 Jun; 7(6):e2290.
Nerve Transfers-A Paradigm Shift in the Reconstructive Ladder.
Cleuren ACA, van der Ent MA, Jiang H, Hunker KL, Yee A, Siemieniak DR, Molema G, Aird WC, Ganesh SK, Ginsburg D
Proceedings of the National Academy of Sciences of the United States of America
The in vivo endothelial cell translatome is highly heterogeneous across vascular beds. Proc Natl Acad Sci U S A. 2019 11 19; 116(47):23618-23624.
The in vivo endothelial cell translatome is highly heterogeneous across vascular beds.
Khor YM, Cuddy S, Harms HJ, Kijewski MF, Park MA, Robertson M, Hyun H, Di Carli MF, Bianchi G, Landau H, Yee A, Sanchorawala V, Ruberg FL, Liao R, Berk J, Falk RH, Dorbala S
European journal of nuclear medicine and molecular imaging
Quantitative [18F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis. Eur J Nucl Med Mol Imaging. 2020 07; 47(8):1998-2009.
Quantitative [18F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis.
Power HA, Kahn LC, Patterson MM, Yee A, Moore AM, Mackinnon SE
Refining Indications for the Supercharge End-to-Side Anterior Interosseous to Ulnar Motor Nerve Transfer in Cubital Tunnel Syndrome. Plast Reconstr Surg. 2020 01; 145(1):106e-116e.
Refining Indications for the Supercharge End-to-Side Anterior Interosseous to Ulnar Motor Nerve Transfer in Cubital Tunnel Syndrome.
How We Approach Smoldering Multiple Myeloma. J Clin Oncol. 2020 04 10; 38(11):1119-1125.
How We Approach Smoldering Multiple Myeloma.
Gavriatopoulou M, Chari A, Chen C, Bahlis N, Vogl DT, Jakubowiak A, Dingli D, Cornell RF, Hofmeister CC, Siegel D, Berdeja JG, Reece D, White D, Lentzsch S, Gasparetto C, Huff CA, Jagannath S, Baz R, Nooka AK, Richter J, Abonour R, Parker TL, Yee AJ, Moreau P, Lonial S, Tuchman S, Weisel KC, Mohty M, Choquet S, Unger TJ, Li K, Chai Y, Li L, Shah J, Shacham S, Kauffman MG, Dimopoulos MA
Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials. Leukemia. 2020 09; 34(9):2430-2440.
Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials.
Yee A, Padovano WM, Rowe AG, Hill EJR, Fox IK, Moore AM, Coert JH, Mackinnon SE
The Effect of Surgical Video on Resident Performance of Carpal Tunnel Release: A Cadaveric Simulation-Based, Prospective, Randomized, Blinded Pilot Study. Plast Reconstr Surg. 2020 06; 145(6):1455-1463.
The Effect of Surgical Video on Resident Performance of Carpal Tunnel Release: A Cadaveric Simulation-Based, Prospective, Randomized, Blinded Pilot Study.
Chang CY, Husseini JS, Moreira A, Simeone FJ, Yee AJ, Bredella MA, Hasserjian R
CT-guided bone marrow aspirations and biopsies: retrospective study and comparison with blind procedures. Skeletal Radiol. 2020 Aug; 49(8):1285-1294.
CT-guided bone marrow aspirations and biopsies: retrospective study and comparison with blind procedures.
Wu F, Buckley S, Bui KC, Yee A, Wu HY, Liu J, Warburton D
Cell cycle arrest in G0/G1 phase by contact inhibition and TGF-beta 1 in mink Mv1Lu lung epithelial cells. Am J Physiol. 1996 May; 270(5 Pt 1):L879-88.
Cell cycle arrest in G0/G1 phase by contact inhibition and TGF-beta 1 in mink Mv1Lu lung epithelial cells.
Treatment of Smoldering Multiple Myeloma: Ready for Prime Time? Cancers (Basel). 2020 May 13; 12(5).
Treatment of Smoldering Multiple Myeloma: Ready for Prime Time?
Wu KJ, Yee A, Zhu NL, Gordon EM, Hall FL
International journal of molecular medicine
Characterization of differential gene expression in monkey arterial neointima following balloon catheter injury. Int J Mol Med. 2000 Oct; 6(4):433-40.
Characterization of differential gene expression in monkey arterial neointima following balloon catheter injury.
Laliberté J, Yee A, Xiong Y, Mitchell BS
Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes. Blood. 1998 Apr 15; 91(8):2896-904.
Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes.
Cuddy SAM, Bravo PE, Falk RH, El-Sady S, Kijewski MF, Park MA, Ruberg FL, Sanchorawala V, Landau H, Yee AJ, Bianchi G, Di Carli MF, Cheng SC, Jerosch-Herold M, Kwong RY, Liao R, Dorbala S
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? JACC Cardiovasc Imaging. 2020 06; 13(6):1325-1336.
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
Pradarelli JC, Pavuluri Quamme SR, Yee A, Faerber AE, Dombrowski JC, King C, Greenberg CC
Surgical coaching to achieve the ABMS vision for the future of continuing board certification. Am J Surg. 2021 01; 221(1):4-10.
Surgical coaching to achieve the ABMS vision for the future of continuing board certification.
Raje N, Chau I, Hyman DM, Ribrag V, Blay JY, Tabernero J, Elez E, Wolf J, Yee AJ, Kaiser M, Landau H, Michot JM, Hollebecque A, Veronese L, Makrutzki M, Pitcher B, Puzanov I, Baselga J
Vemurafenib in Patients With Relapsed Refractory Multiple Myeloma Harboring BRAFV600 Mutations: A Cohort of the Histology-Independent VE-BASKET Study. JCO Precis Oncol. 2018; 2.
Vemurafenib in Patients With Relapsed Refractory Multiple Myeloma Harboring BRAFV600 Mutations: A Cohort of the Histology-Independent VE-BASKET Study.
Dengler J, Dolen U, Patterson JMM, Davidge KM, Kahn LC, Yee A, Mackinnon SE
Supercharge End-to-Side Anterior Interosseous-to-Ulnar Motor Nerve Transfer Restores Intrinsic Function in Cubital Tunnel Syndrome. Plast Reconstr Surg. 2020 10; 146(4):808-818.
Supercharge End-to-Side Anterior Interosseous-to-Ulnar Motor Nerve Transfer Restores Intrinsic Function in Cubital Tunnel Syndrome.
Padovano WM, Dengler J, Patterson MM, Yee A, Snyder-Warwick AK, Wood MD, Moore AM, Mackinnon SE
Incidence of Nerve Injury After Extremity Trauma in the United States. Hand (N Y). 2022 07; 17(4):615-623.
Incidence of Nerve Injury After Extremity Trauma in the United States.
Yee A, Li J, Lilly J, Hildebrandt S, Seidelman WE, Brown D, Kopar P, Coert JH, Mackinnon SE, Israel HA
Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft
Oral and maxillofacial surgeons' assessment of the role of Pernkopf's atlas in surgical practice. Ann Anat. 2021 Mar; 234:151614.
Oral and maxillofacial surgeons' assessment of the role of Pernkopf's atlas in surgical practice.
Yee A, Padovano WM, Fox IK, Hill EJR, Rowe AG, Brunt LM, Moore AM, Snyder-Warwick AK, Kahn LC, Wood MD, Coert JH, Mackinnon SE
Video-based Learning in Surgery: Establishing Surgeon Engagement and Utilization of Variable-duration Videos. Ann Surg. 2020 12; 272(6):1012-1019.
Video-based Learning in Surgery: Establishing Surgeon Engagement and Utilization of Variable-duration Videos.
Lamont EB, Yee AJ, Goldberg SL, Siegel DS, Norden AD
Associations Between Amplification (1q) and Prior Cancer in a Real-World De Novo Myeloma Cohort. JNCI Cancer Spectr. 2021 02; 5(1).
Associations Between Amplification (1q) and Prior Cancer in a Real-World De Novo Myeloma Cohort.
Dengler J, Padovano WM, Davidge K, McKay V, Yee A, Mackinnon SE
Dissemination and Implementation Science in Plastic and Reconstructive Surgery: Perfecting, Protecting, and Promoting the Innovation That Defines Our Specialty. Plast Reconstr Surg. 2021 02 01; 147(2):303e-313e.
Dissemination and Implementation Science in Plastic and Reconstructive Surgery: Perfecting, Protecting, and Promoting the Innovation That Defines Our Specialty.
Caro J, Al Hadidi S, Usmani S, Yee AJ, Raje N, Davies FE
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
How to Treat High-Risk Myeloma at Diagnosis and Relapse. Am Soc Clin Oncol Educ Book. 2021 Mar; 41:291-309.
How to Treat High-Risk Myeloma at Diagnosis and Relapse.
The role of carfilzomib in relapsed/refractory multiple myeloma. Ther Adv Hematol. 2021; 12:20406207211019612.
The role of carfilzomib in relapsed/refractory multiple myeloma.
Yee A, Dai M, Croteau SE, Shavit JA, Pipe SW, Siemieniak D, Meng F, Ginsburg D
Journal of thrombosis and haemostasis : JTH
Phage display broadly identifies inhibitor-reactive regions in von Willebrand factor. J Thromb Haemost. 2021 11; 19(11):2702-2709.
Phage display broadly identifies inhibitor-reactive regions in von Willebrand factor.
Castillo JJ, Meid K, Gustine JN, Leventoff C, White T, Flynn CA, Sarosiek S, Demos MG, Guerrera ML, Kofides A, Liu X, Munshi M, Tsakmaklis N, Xu L, Yang G, Branagan AR, O'Donnell E, Raje N, Yee AJ, Patterson CJ, Hunter ZR, Treon SP
Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia. Leukemia. 2022 02; 36(2):532-539.
Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia.
Waldschmidt JM, Kloeber JA, Anand P, Frede J, Kokkalis A, Dimitrova V, Potdar S, Nair MS, Vijaykumar T, Im NG, Guillaumet-Adkins A, Chopra N, Stuart H, Budano L, Sotudeh N, Guo G, Grassberger C, Yee AJ, Laubach JP, Richardson PG, Anderson KC, Raje NS, Knoechel B, Lohr JG
Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma. Clin Cancer Res. 2021 12 01; 27(23):6432-6444.
Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma.
Huttinger ZM, Haynes LM, Yee A, Kretz CA, Holding ML, Siemieniak DR, Lawrence DA, Ginsburg D
Deep mutational scanning of the plasminogen activator inhibitor-1 functional landscape. Sci Rep. 2021 09 22; 11(1):18827.
Deep mutational scanning of the plasminogen activator inhibitor-1 functional landscape.
Yee AJ, Yoo JU, Marsolais EB, Carlson G, Poe-Kochert C, Bohlman HH, Emery SE
The Journal of bone and joint surgery. American volume
Use of a postoperative lumbar corset after lumbar spinal arthrodesis for degenerative conditions of the spine. A prospective randomized trial. J Bone Joint Surg Am. 2008 Oct; 90(10):2062-8.
Use of a postoperative lumbar corset after lumbar spinal arthrodesis for degenerative conditions of the spine. A prospective randomized trial.
Frede J, Anand P, Sotudeh N, Pinto RA, Nair MS, Stuart H, Yee AJ, Vijaykumar T, Waldschmidt JM, Potdar S, Kloeber JA, Kokkalis A, Dimitrova V, Mann M, Laubach JP, Richardson PG, Anderson KC, Raje NS, Knoechel B, Lohr JG
Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma. Nat Cell Biol. 2021 11; 23(11):1199-1211.
Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma.
Shapiro YN, Peppercorn JM, Yee AJ, Branagan AR, Raje NS, Donnell EKO
Lifestyle considerations in multiple myeloma. Blood Cancer J. 2021 10 26; 11(10):172.
Lifestyle considerations in multiple myeloma.
Observations of the near-wall accumulation of suspended particles due to shear and electroosmotic flow in opposite directions. Electrophoresis. 2021 11; 42(21-22):2215-2222.
Observations of the near-wall accumulation of suspended particles due to shear and electroosmotic flow in opposite directions.
Hematology. American Society of Hematology. Education Program
Minimal residual disease in multiple myeloma: why, when, where. Hematology Am Soc Hematol Educ Program. 2021 12 10; 2021(1):37-45.
Minimal residual disease in multiple myeloma: why, when, where.
Cuddy SAM, Jerosch-Herold M, Falk RH, Kijewski MF, Singh V, Ruberg FL, Sanchorawala V, Landau H, Maurer MS, Yee AJ, Bianchi G, Di Carli MF, Liao R, Kwong RY, Dorbala S
Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy. JACC Cardiovasc Imaging. 2022 04; 15(4):594-603.
Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy.
Gregory GP, Kumar S, Wang D, Mahadevan D, Walker P, Wagner-Johnston N, Escobar C, Bannerji R, Bhutani D, Chang J, Hernandez-Ilizaliturri FJ, Klein A, Pagel JM, Rybka W, Yee AJ, Mohrbacher A, Huang M, Farooqui M, Marinello P, Quach H
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study. Blood Adv. 2022 02 22; 6(4):1232-1242.
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study.
Waldschmidt JM, Yee AJ, Vijaykumar T, Pinto RA, Frede J, Anand P, Bianchi G, Guo G, Potdar S, Seifer C, Nair MS, Kokkalis A, Kloeber JA, Shapiro S, Budano L, Mann M, Friedman R, Lipe B, Campagnaro E, O'Donnell EK, Zhang CZ, Laubach JP, Munshi NC, Richardson PG, Anderson KC, Raje NS, Knoechel B, Lohr JG
Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myeloma. Leukemia. 2022 04; 36(4):1078-1087.
Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myeloma.
Raje NS, Anaissie E, Kumar SK, Lonial S, Martin T, Gertz MA, Krishnan A, Hari P, Ludwig H, O'Donnell E, Yee A, Kaufman JL, Cohen AD, Garderet L, Wechalekar AF, Terpos E, Khatry N, Niesvizky R, Yi Q, Joshua DE, Saikia T, Leung N, Engelhardt M, Mothy M, Branagan A, Chari A, Reiman AJ, Lipe B, Richter J, Rajkumar SV, Miguel JS, Anderson KC, Stadtmauer EA, Prabhala RH, McCarthy PL, Munshi NC
Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group. Lancet Haematol. 2022 Feb; 9(2):e143-e161.
Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group.
O'Gorman P, Laubach JP, O'Dwyer ME, Krawczyk J, Yee AJ, Gilligan O, Cahill MR, Rosenblatt J, Quinn J, Murphy PT, DiPietro H, Perera MR, Crotty GM, Cummings K, Hayden PJ, Browne P, Savell A, O'Leary HM, O'Keeffe D, Masone K, Hennessy BJ, Guerrero Garcia T, Scott K, Saeed K, Bianchi G, Dowling P, Tierney C, Richardson PG
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma. Am J Hematol. 2022 05; 97(5):562-573.
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma.
O'Donnell EK, Shapiro YN, Yee AJ, Nadeem O, Hu BY, Laubach JP, Branagan AR, Anderson KC, Mo CC, Munshi NC, Ghobrial IM, Sperling AS, Agyemang EA, Burke JN, Harrington CC, Richardson PG, Raje NS, El-Jawahri A
Quality of life, psychological distress, and prognostic perceptions in patients with multiple myeloma. Cancer. 2022 05 15; 128(10):1996-2004.
Quality of life, psychological distress, and prognostic perceptions in patients with multiple myeloma.
Orlando MS, Greenberg CC, Pavuluri Quamme SR, Yee A, Faerber AE, King CR
American journal of obstetrics and gynecology
Surgical coaching in obstetrics and gynecology: an evidence-based strategy to elevate surgical education and promote lifelong learning. Am J Obstet Gynecol. 2022 07; 227(1):51-56.
Surgical coaching in obstetrics and gynecology: an evidence-based strategy to elevate surgical education and promote lifelong learning.
Near-wall velocities of particles suspended in shear flow and a streamwise electric field. Electrophoresis. 2022 Nov; 43(21-22):2093-2103.
Near-wall velocities of particles suspended in shear flow and a streamwise electric field.
Frigault MJ, Bishop MR, Rosenblatt J, O'Donnell EK, Raje N, Cook D, Yee AJ, Logan E, Avigan DE, Jakubowiak A, Shaw K, Daley H, Nikiforow S, Griffin F, Cornwell C, Shen A, Heery C, Maus MV
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma. Blood Adv. 2023 03 14; 7(5):768-777.
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma.
Scullen T, Santo L, Vallet S, Fulciniti M, Eda H, Cirstea D, Patel K, Nemani N, Yee A, Mahindra A, Raje N
Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategy. Leukemia. 2013 Aug; 27(8):1715-21.
Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategy.
O'Donnell EK, Shapiro YN, Yee AJ, Nadeem O, Laubach JP, Branagan AR, Anderson KC, Mo CC, Munshi NC, Ghobrial IM, Sperling AS, Agyemang EA, Burke JN, Harrington CC, Hu BY, Richardson PG, Raje NS, El-Jawahri A
Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma. Blood Adv. 2022 09 13; 6(17):4967-4974.
Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma.
Kumar S, Baizer L, Callander NS, Giralt SA, Hillengass J, Freidlin B, Hoering A, Richardson PG, Schwartz EI, Reiman A, Lentzsch S, McCarthy PL, Jagannath S, Yee AJ, Little RF, Raje NS
Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee. Blood Cancer J. 2022 06 29; 12(6):98.
Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee.
von Willebrand Factor, Free Hemoglobin and Thrombosis in ECMO. Front Med (Lausanne). 2018; 5:228.
von Willebrand Factor, Free Hemoglobin and Thrombosis in ECMO.
Richardson PG, Jacobus SJ, Weller EA, Hassoun H, Lonial S, Raje NS, Medvedova E, McCarthy PL, Libby EN, Voorhees PM, Orlowski RZ, Anderson LD, Zonder JA, Milner CP, Gasparetto C, Agha ME, Khan AM, Hurd DD, Gowin K, Kamble RT, Jagannath S, Nathwani N, Alsina M, Cornell RF, Hashmi H, Campagnaro EL, Andreescu AC, Gentile T, Liedtke M, Godby KN, Cohen AD, Openshaw TH, Pasquini MC, Giralt SA, Kaufman JL, Yee AJ, Scott E, Torka P, Foley A, Fulciniti M, Hebert K, Samur MK, Masone K, Maglio ME, Zeytoonjian AA, Nadeem O, Schlossman RL, Laubach JP, Paba-Prada C, Ghobrial IM, Perrot A, Moreau P, Avet-Loiseau H, Attal M, Anderson KC, Munshi NC
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma. N Engl J Med. 2022 07 14; 387(2):132-147.
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
Yee A, Padovano WM, Patterson JMM, Pet MA, Zazulia AR, Dengler J, Novak CB, Coert JH, Mackinnon SE
Developing a Video-Based Learning Module to Teach Decision-Making for Cubital Tunnel Surgery. Plast Reconstr Surg. 2022 10 01; 150(4):810e-822e.
Developing a Video-Based Learning Module to Teach Decision-Making for Cubital Tunnel Surgery.
Bray M, Guzel MA, Lam F, Yee A, Cruz MA, Rumbaut RE
High levels of von Willebrand factor with reduced specific activities in hospitalized patients with or without COVID-19. J Thromb Thrombolysis. 2022 Aug; 54(2):211-216.
High levels of von Willebrand factor with reduced specific activities in hospitalized patients with or without COVID-19.
Haynes LM, Huttinger ZM, Yee A, Kretz CA, Siemieniak DR, Lawrence DA, Ginsburg D
Deep mutational scanning and massively parallel kinetics of plasminogen activator inhibitor-1 functional stability to probe its latency transition. J Biol Chem. 2022 12; 298(12):102608.
Deep mutational scanning and massively parallel kinetics of plasminogen activator inhibitor-1 functional stability to probe its latency transition.
Miller KC, Johnson PC, Abramson JS, Soumerai JD, Yee AJ, Branagan AR, O'Donnell EK, Saucier A, Jacobson CA, Frigault MJ, Raje NS
Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma. Blood Cancer J. 2022 11 01; 12(10):146.
Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma.
Barbour JR, Yee A, Moore AM, Trulock EP, Buchowski JM, Mackinnon SE
Cadaveric nerve allotransplantation in the treatment of persistent thoracic neuralgia. Ann Thorac Surg. 2015 Apr; 99(4):1414-7.
Cadaveric nerve allotransplantation in the treatment of persistent thoracic neuralgia.
Sklavenitis-Pistofidis R, Aranha MP, Redd RA, Baginska J, Haradhvala NJ, Hallisey M, Dutta AK, Savell A, Varmeh S, Heilpern-Mallory D, Ujwary S, Zavidij O, Aguet F, Su NK, Lightbody ED, Bustoros M, Tahri S, Mouhieddine TH, Wu T, Flechon L, Anand S, Rosenblatt JM, Zonder J, Vredenburgh JJ, Boruchov A, Bhutani M, Usmani SZ, Matous J, Yee AJ, Jakubowiak A, Laubach J, Manier S, Nadeem O, Richardson P, Badros AZ, Mateos MV, Trippa L, Getz G, Ghobrial IM
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma. Cancer Cell. 2022 11 14; 40(11):1358-1373.e8.
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma.
The Flow Dependent Adhesion of von Willebrand Factor (VWF)-A1 Functionalized Nanoparticles in an in Vitro Coronary Stenosis Model. Molecules. 2019 Jul 24; 24(15).
The Flow Dependent Adhesion of von Willebrand Factor (VWF)-A1 Functionalized Nanoparticles in an in Vitro Coronary Stenosis Model.
Leaving Lytic Lesions-Is There New Role for Radiation in Multiple Myeloma in the CAR T Era? Pract Radiat Oncol. 2022 Sep-Oct; 12(5):367-369.
Leaving Lytic Lesions-Is There New Role for Radiation in Multiple Myeloma in the CAR T Era?
Lei MM, Tavares E, Buzgo E, Lou U, Raje N, Yee AJ
Denosumab versus intravenous bisphosphonate use for hypercalcemia in multiple myeloma. Leuk Lymphoma. 2022 12; 63(13):3249-3252.
Denosumab versus intravenous bisphosphonate use for hypercalcemia in multiple myeloma.
Wang Y, Yee A, Bernstein Z, O'Donnell E, Raje N, Mahmood U
Carbon-11-Labeled Methionine PET/CT in Patients With FDG-Occult Multiple Myeloma: A Prospective Pilot Study. AJR Am J Roentgenol. 2023 04; 220(4):578-579.
Carbon-11-Labeled Methionine PET/CT in Patients With FDG-Occult Multiple Myeloma: A Prospective Pilot Study.
Yee A, Coombs DM, Hildebrandt S, Seidelman WE, Coer JH, Mackinnon SE
Nerve Surgeons' Assessment of the Role of Eduard Pernkopf's Atlas of Topographic and Applied Human Anatomy in Surgical Practice. J Biocommun. 2021; 45(1):E7.
Martinez-Vargas M, Cebula A, Brubaker LS, Seshadri N, Lam FW, Loor M, Rosengart TK, Yee A, Rumbaut RE, Cruz MA
A novel interaction between extracellular vimentin and fibrinogen in fibrin formation. Thromb Res. 2023 01; 221:97-104.
A novel interaction between extracellular vimentin and fibrinogen in fibrin formation.
Hill EJR, Patterson JMM, Yee A, Crock LW, Mackinnon SE
What is Operative? Conceptualizing Neuralgia: Neuroma, Compression Neuropathy, Painful Hyperalgesia, and Phantom Nerve Pain. J Hand Surg Glob Online. 2023 Jan; 5(1):126-132.
What is Operative? Conceptualizing Neuralgia: Neuroma, Compression Neuropathy, Painful Hyperalgesia, and Phantom Nerve Pain.
Hill EJR, Padovano W, Krauss EM, Patterson JMM, Yee A, Crock LW, Mackinnon SE
Decompression with Brachioradialis Tenotomy Improves Pain and Quality of Life in Patients with Radial Sensory Nerve Compression. Plast Reconstr Surg. 2023 04 01; 151(4):641e-650e.
Decompression with Brachioradialis Tenotomy Improves Pain and Quality of Life in Patients with Radial Sensory Nerve Compression.
Graham CE, Lee WH, Wiggin HR, Supper VM, Leick MB, Birocchi F, Yee AJ, Petrichenko A, Everett J, Bushman FD, Sadrzadeh H, Rapalino O, Chiu D, Arrillaga-Romany I, Maus MV, Frigault MJ, Gallagher KME
Chemotherapy-induced reversal of ciltacabtagene autoleucel-associated movement and neurocognitive toxicity. Blood. 2023 10 05; 142(14):1248-1252.
Chemotherapy-induced reversal of ciltacabtagene autoleucel-associated movement and neurocognitive toxicity.
Active control time: an objective performance metric for trainee participation in robotic surgery. J Robot Surg. 2023 Oct; 17(5):2117-2123.
Active control time: an objective performance metric for trainee participation in robotic surgery.
Schuler N, Shepard L, Saxton A, Russo J, Johnston D, Saba P, Holler T, Smith A, Kulason S, Yee A, Ghazi A
Predicting Surgical Experience After Robotic Nerve-sparing Radical Prostatectomy Simulation Using a Machine Learning-based Multimodal Analysis of Objective Performance Metrics. Urol Pract. 2023 09; 10(5):447-455.
Predicting Surgical Experience After Robotic Nerve-sparing Radical Prostatectomy Simulation Using a Machine Learning-based Multimodal Analysis of Objective Performance Metrics.
Karschnia P, Miller KC, Yee AJ, Rejeski K, Johnson PC, Raje N, Frigault MJ, Dietrich J
Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells. Blood. 2023 10 05; 142(14):1243-1248.
Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T cells.
Choksi S, Bitner DP, Carsky K, Addison P, Webman R, Andrews R, Kowalski R, Dawson M, Dronsky V, Yee A, Jarc A, Filicori F
Kinematic data profile and clinical outcomes in robotic inguinal hernia repairs: a pilot study. Surg Endosc. 2023 10; 37(10):8035-8042.
Kinematic data profile and clinical outcomes in robotic inguinal hernia repairs: a pilot study.
Jagannath S, Anderson MA, Yee AJ, Hasserjian RP
Case 29-2023: A 34-Year-Old Woman with Abdominal Distention and Acute Kidney Injury. N Engl J Med. 2023 09 21; 389(12):1133-1143.
Case 29-2023: A 34-Year-Old Woman with Abdominal Distention and Acute Kidney Injury.
Mo CC, Yee AJ, Midha S, Hartley-Brown MA, Nadeem O, O'Donnell EK, Bianchi G, Sperling AS, Laubach JP, Richardson PG
Selinexor: Targeting a novel pathway in multiple myeloma. EJHaem. 2023 Aug; 4(3):792-810.
Selinexor: Targeting a novel pathway in multiple myeloma.
Ababneh HS, Yee AJ, Raje NS, Martin S, Frigault MJ, Ng AK, Patel CG
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Radiation therapy as a bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy. Radiother Oncol. 2023 12; 189:109933.
Radiation therapy as a bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy.
Bitner DP, Choksi S, Carsky K, Addison P, Andrews R, Kowalski R, Reisner A, Farrell A, Jain K, Dronsky V, Jarc A, Yee A, Filicori F
Kinematic metrics and surgeon experience in robotic cholecystectomies: a pilot study on breaking down technical performance. Surg Endosc. 2024 02; 38(2):913-921.
Kinematic metrics and surgeon experience in robotic cholecystectomies: a pilot study on breaking down technical performance.
Datar Y, Clerc OF, Cuddy SAM, Kim S, Taylor A, Neri JC, Benz DC, Bianchi G, Yee AJ, Sanchorawala V, Ruberg FL, Landau H, Liao R, Kijewski MF, Jerosch-Herold M, Kwong RY, Di Carli MF, Falk RH, Dorbala S
European heart journal. Cardiovascular Imaging
Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis. Eur Heart J Cardiovasc Imaging. 2024 Apr 30; 25(5):687-697.
Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis.
Al Jurdi A, Cohen Bucay A, Riella LV, Yee AJ, Abdelmalek C, Klepeis V, Kimura S, Safa K
Successful Treatment of Posttransplant Monoclonal Gammopathy-associated C3 Glomerulopathy With Plasma Cell Clone-directed Therapy. Transplant Direct. 2024 May; 10(5):e1616.
Successful Treatment of Posttransplant Monoclonal Gammopathy-associated C3 Glomerulopathy With Plasma Cell Clone-directed Therapy.
O'Donnell E, Mo C, Yee AJ, Nadeem O, Laubach J, Rosenblatt J, Munshi N, Midha S, Cirstea D, Chrysafi P, Horick N, Richardson PG, Raje N
Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 trial. Lancet Haematol. 2024 Jun; 11(6):e415-e424.
Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 trial.
Boulanger MC, Tieger MG, Eliott D, Yee AJ
Intravitreal aflibercept confounds interpretation of plasma VEGF (vascular endothelial growth factor) levels in POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome. EJHaem. 2024 Apr; 5(2):421-422.
Intravitreal aflibercept confounds interpretation of plasma VEGF (vascular endothelial growth factor) levels in POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome.
Katznelson E, Jerosch-Herold M, Cuddy SAM, Clerc OF, Benz DC, Taylor A, Rao S, Kijewski MF, Liao R, Landau H, Yee AJ, Ruberg FL, Di Carli MF, Falk RH, Kwong RY, Dorbala S
Mechanisms of left ventricular systolic dysfunction in light chain amyloidosis: a multiparametric cardiac MRI study. Front Cardiovasc Med. 2024; 11:1371810.
Mechanisms of left ventricular systolic dysfunction in light chain amyloidosis: a multiparametric cardiac MRI study.
Tuan TL, Cheung DT, Wu LT, Yee A, Gabriel S, Han B, Morton L, Nimni ME, Hall FL
Engineering, expression and renaturation of targeted TGF-beta fusion proteins. Connect Tissue Res. 1996; 34(1):1-9.
Engineering, expression and renaturation of targeted TGF-beta fusion proteins.
Improving outcomes with anti-BCMA bispecific antibodies with attention to infection. Blood Cancer J. 2024 07 08; 14(1):110.
Improving outcomes with anti-BCMA bispecific antibodies with attention to infection.
Liu Y, Mo CC, Hartley-Brown MA, Sperling AS, Midha S, Yee AJ, Bianchi G, Piper C, Tattersall A, Nadeem O, Laubach JP, Richardson PG
Targeting Ikaros and Aiolos: reviewing novel protein degraders for the treatment of multiple myeloma, with a focus on iberdomide and mezigdomide. Expert Rev Hematol. 2024 Aug; 17(8):445-465.
Targeting Ikaros and Aiolos: reviewing novel protein degraders for the treatment of multiple myeloma, with a focus on iberdomide and mezigdomide.
Clerc OF, Vijayakumar S, Cuddy SAM, Bianchi G, Canseco Neri J, Taylor A, Benz DC, Datar Y, Kijewski MF, Yee AJ, Ruberg FL, Liao R, Falk RH, Sanchorawala V, Dorbala S
Functional Status and Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes, and Outcomes. JACC Heart Fail. 2024 Dec; 12(12):1994-2006.
Functional Status and Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes, and Outcomes.
An ATLAS to map MRD with peripheral blood. Blood. 2024 08 29; 144(9):919-920.
An ATLAS to map MRD with peripheral blood.
Gerull WD, Kulason S, Shields MC, Yee A, Awad MM
Journal of the American College of Surgeons
Impact of Robotic Surgery Objective Performance Indicators: A Systematic Review. J Am Coll Surg. 2025 Feb 01; 240(2):201-210.
Impact of Robotic Surgery Objective Performance Indicators: A Systematic Review.
Dimopoulos MA, Migkou M, Bhutani M, Ailawadhi S, Kalff A, Walcott FL, Pore N, Brown M, Wang F, Cheng LI, Kagiampakis I, Williams M, Kinneer K, Wu Y, Jiang Y, Kubiak RJ, Zonder JA, Larsen J, Sirdesai S, Yee AJ, Kumar S
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma. Leuk Lymphoma. 2024 12; 65(12):1789-1800.
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma.
Yee AJ, Laubach JP, Campagnaro EL, Lipe BC, Nadeem O, Friedman RS, Cole CE, O'Donnell EK, Bianchi G, Branagan AR, Schlossman RL, Shapiro SJ, Harrington CC, Burke JN, Gammon MT, Lively KJ, Reimonn CA, Andrade DX, Redd R, Lohr JG, Anderson KC, Richardson PG, Raje NS
Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma. Blood Adv. 2025 Mar 11; 9(5):1163-1170.
Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma.
Waldschmidt JM, Sotudeh N, Arora S, Vijaykumar T, Anand P, Stuart H, Frede J, Campbell T, Kaiser SM, Zheng X, Munshi NC, Anderson KC, Einsele H, Yee AJ, Knoechel B, Lohr JG, Raje NS
Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma. Blood Adv. 2025 Mar 11; 9(5):1132-1136.
Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma.
Nakamoto-Matsubara R, Nardi V, Horick N, Fukushima T, Han RS, Shome R, Ochi K, Panaroni C, Fulzele K, Rexha F, Branagan AR, Cirstea D, Yee AJ, Scadden DT, Raje NS
Integration of clinical outcomes and molecular features in extramedullary disease in multiple myeloma. Blood Cancer J. 2024 12 23; 14(1):224.
Integration of clinical outcomes and molecular features in extramedullary disease in multiple myeloma.
Yancy CW, Guseh JS, Ghoshhajra BG, Falk RH, Yee AJ, Hutchison BM
Case 3-2025: A 54-Year-Old Man with Exertional Dyspnea and Chest Pain. N Engl J Med. 2025 Jan 23; 392(4):383-394.
Case 3-2025: A 54-Year-Old Man with Exertional Dyspnea and Chest Pain.
Cirstea D, Shome R, Samur M, Talluri S, Connolly JJ, Wright AJ, Duvallet E, Joyce ANR, Lively K, Basinsky G, Yee AJ, Chase CC, Malek E, Niesvizky R, Richardson PG, Raje NS
Immune profiling of smoldering multiple myeloma patients treated in a phase lb study of PVX-410 vaccine targeting XBP1/CD138/CS1 antigens, and citarinostat, a histone deacetylase inhibitor (HDACi) with and without lenalidomide. Blood Cancer J. 2025 Apr 24; 15(1):77.
Immune profiling of smoldering multiple myeloma patients treated in a phase lb study of PVX-410 vaccine targeting XBP1/CD138/CS1 antigens, and citarinostat, a histone deacetylase inhibitor (HDACi) with and without lenalidomide.
Kampmeier J, Behrens A, Wang Y, Yee A, Anderson WF, Hall FL, Gordon EM, McDonnell PJ
Inhibition of rabbit keratocyte and human fetal lens epithelial cell proliferation by retrovirus-mediated transfer of antisense cyclin G1 and antisense MAT1 constructs. Hum Gene Ther. 2000 Jan 01; 11(1):1-8.
Inhibition of rabbit keratocyte and human fetal lens epithelial cell proliferation by retrovirus-mediated transfer of antisense cyclin G1 and antisense MAT1 constructs.
Blumenberg V, Puliafito BR, Graham CE, Leick MB, Chowdhury MR, King M, Harris DL, Raje NS, Branagan AR, Yee AJ, Cirstea D, Gallagher KME, Dietrich J, Maus MV, Frigault MJ
Cyclophosphamide mitigates non-ICANS neurotoxicities following ciltacabtagene autoleucel treatment. Blood. 2025 Jun 05; 145(23):2788-2793.
Cyclophosphamide mitigates non-ICANS neurotoxicities following ciltacabtagene autoleucel treatment.
Gustine JN, Branagan AR, Cirstea DD, Rexha F, Han R, Yee AJ, Maus MV, Frigault MJ, Raje NS
Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma. Blood Adv. 2025 Jun 24; 9(12):3026-3030.
Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myeloma.
Yee A, Nichols MA, Wu L, Hall FL, Kobayashi R, Xiong Y
Molecular cloning of CDK7-associated human MAT1, a cyclin-dependent kinase-activating kinase (CAK) assembly factor. Cancer Res. 1995 Dec 15; 55(24):6058-62.
Molecular cloning of CDK7-associated human MAT1, a cyclin-dependent kinase-activating kinase (CAK) assembly factor.
Kim EB, Malespini JE, Lei M, Han SS, Minsky CW, Branagan AR, O'Donnell EK, Cirstea D, Raje NS, Yee AJ
Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury. Blood Adv. 2025 Jul 08; 9(13):3129-3135.
Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury.
Eda H, Santo L, Cirstea DD, Yee AJ, Scullen TA, Nemani N, Mishima Y, Waterman PR, Arastu-Kapur S, Evans E, Singh J, Kirk CJ, Westlin WF, Raje NS
A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity. Leukemia. 2014 Sep; 28(9):1892-901.
A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity.
Journal of the National Comprehensive Cancer Network : JNCCN
Advances in supportive care for multiple myeloma. J Natl Compr Canc Netw. 2014 Apr; 12(4):502-11.
Advances in supportive care for multiple myeloma.
Reply: The Effect of Surgical Video on Resident Performance of Carpal Tunnel Release: A Cadaveric Simulation-Based, Prospective, Randomized, Blinded Pilot Study. Plast Reconstr Surg. 2021 08 01; 148(2):311e-312e.
Reply: The Effect of Surgical Video on Resident Performance of Carpal Tunnel Release: A Cadaveric Simulation-Based, Prospective, Randomized, Blinded Pilot Study.
Clinical applications of mass spectrometry in multiple myeloma. Blood Adv. 2025 Dec 23; 9(24):6593-6603.
Clinical applications of mass spectrometry in multiple myeloma.
Gross AR, Paquin JP, Dupont G, Blanchette S, Lalonde P, Cristie T, Graham N, Kay TM, Burnie SJ, Gelley G, Goldsmith CH, Forget M, Santaguida PL, Yee AJ, Radisic GG, Hoving JL, Bronfort G
Exercises for mechanical neck disorders: A Cochrane review update. Man Ther. 2016 Aug; 24:25-45.
Exercises for mechanical neck disorders: A Cochrane review update.
Flynn CJ, Danjoux C, Wong J, Christakis M, Rubenstein J, Yee A, Yip D, Chow E
Two cases of acrometastasis to the hands and review of the literature. Curr Oncol. 2008 Oct; 15(5):51-8.
Two cases of acrometastasis to the hands and review of the literature.
Pripotnev S, Bucelli RC, Patterson JMM, Yee A, Pet MA, Mackinnon S
Interpreting Electrodiagnostic Studies for the Management of Nerve Injury. J Hand Surg Am. 2022 09; 47(9):881-889.
Interpreting Electrodiagnostic Studies for the Management of Nerve Injury.
Martinez-Vargas M, Courson J, Gardea L, Sen M, Yee A, Rumbaut R, Cruz MA
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
The impact of von Willebrand factor on fibrin formation and structure unveiled with type 3 von Willebrand disease plasma. Blood Coagul Fibrinolysis. 2024 Jul 01; 35(5):256-264.
The impact of von Willebrand factor on fibrin formation and structure unveiled with type 3 von Willebrand disease plasma.
Branagan AR, Mo C, Lei M, Gustine JN, Yee AJ, O'Donnell E, Castillo JJ, Nadeem O, Flynn C, Bernstein Z, Nakamoto-Matsubara R, Meid K, Verma R, Hunter ZR, Guerrera ML, Alter G, Burke J, Harrington C, Agyemang E, Gammon M, Lively K, Packer L, Horick N, Laubach J, Mitsiades CS, Munshi N, Anderson KC, Treon SP, Richardson PG, Raje NS, Sarosiek SR
Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia. Blood Adv. 2025 Sep 23; 9(18):4568-4579.
Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia.
Rodriguez C, Rodriguez T, Kentos A, Driessen C, Sunami K, Lesokhin AM, Yee AJ, Minella AC, Maraboina R, Upreti VV, Zhou D, Shabooti M, Stieglmaier J, Quach H
BCMA-targeting BiTE molecule AMG 420 in relapsed or refractory multiple myeloma: a phase 1b open-label expansion study. Leuk Lymphoma. 2025 Nov; 66(11):2108-2117.
BCMA-targeting BiTE molecule AMG 420 in relapsed or refractory multiple myeloma: a phase 1b open-label expansion study.
Li WS, AbuHasan Q, Athanasiadis DI, Yee A, Stefanidis D
Objective performance indicators during robotic Roux-en-Y gastric bypass distinguish experienced from trainee surgeons: a cross-sectional study. Surg Endosc. 2025 Aug; 39(8):5178-5188.
Objective performance indicators during robotic Roux-en-Y gastric bypass distinguish experienced from trainee surgeons: a cross-sectional study.
Finkelstein-Fox L, Denninger JW, Walsh LE, Laubach JP, Yee AJ, O'Donnell E, Macklin EA, Gu X, Muzikansky A, Libermann TA, Nicolosi G, Richardson PG, Raje NS, Fricchione GL, Perez GK, Traeger LN, Chad-Friedman E, Park ER
Psychosocial and NF-?B Activity Effects of the Stress Management and Resiliency Training: Relaxation Response Resiliency Program (SMART-3RP) on Patients With MGUS and Smoldering Multiple Myeloma: A Randomized Waitlist Control Trial. Psychooncology. 2025 Jul; 34(7):e70216.
Psychosocial and NF-?B Activity Effects of the Stress Management and Resiliency Training: Relaxation Response Resiliency Program (SMART-3RP) on Patients With MGUS and Smoldering Multiple Myeloma: A Randomized Waitlist Control Trial.
Gal ZT, Wetzel EA, Nahed BV, Saylor PJ, Hirsch JA, Marciscano AE, Raje NS, Tobert DG, Yee AJ, Shankar GM
The spine journal : official journal of the North American Spine Society
Efficacy of bone-modifying agents in preventing vertebral complications of multiple myeloma: a systematic review and meta-analysis. Spine J. 2026 Apr; 26(4):806-820.
Efficacy of bone-modifying agents in preventing vertebral complications of multiple myeloma: a systematic review and meta-analysis.
Gustine JN, Scaringi JA, Bauer F, Cirstea DD, Branagan AR, Puliafito BR, Maus MV, Frigault MJ, Yee AJ, Mahmood U, Raje NS
Prognostic value of serological and PET/CT response kinetics in patients with multiple myeloma treated with BCMA CAR-T. Leukemia. 2026 Feb; 40(2):440-443.
Prognostic value of serological and PET/CT response kinetics in patients with multiple myeloma treated with BCMA CAR-T.
Tindal EW, Ballo M, Nussbaum JE, Choksi S, Yee A, Filicori F
Quantifying surgical complexity: how smoothness metrics vary in robotic cholecystectomy. Surg Endosc. 2026 Feb; 40(2):1686-1693.
Quantifying surgical complexity: how smoothness metrics vary in robotic cholecystectomy.
Blumenberg V, Birocchi F, Shih A, Escobar G, Mucci A, Armstrong A, Cirstea DD, Harris DL, Bozym DJ, Puliafito BR, Newcomb RA, Dhawale TM, Johnson PC, El-Jawahri A, Jeffrey R, Barselau A, Li A, Emmanuel-Alejandro E, Cook D, Lindell KA, Luk SO, Chaffee R, Yee AJ, Branagan AR, Raje NS, Graham C, Hammond SP, Bushman FD, Roche AM, Reddy S, McFarland AG, Chen YB, Choi BD, Mount CW, Dougan M, Nardi V, Sohani A, Gallagher KME, Maus MV, Frigault MJ, Leick MB
Ruxolitinib for Ciltacabtagene Autoleucel-Associated Refractory Diarrhea. Blood. 2026 Jan 27.
Ruxolitinib for Ciltacabtagene Autoleucel-Associated Refractory Diarrhea.
Weber-Adrian D, Thévenot E, O'Reilly MA, Oakden W, Akens MK, Ellens N, Markham-Coultes K, Burgess A, Finkelstein J, Yee AJ, Whyne CM, Foust KD, Kaspar BK, Stanisz GJ, Chopra R, Hynynen K, Aubert I
Gene delivery to the spinal cord using MRI-guided focused ultrasound. Gene Ther. 2015 Jul; 22(7):568-77.
Gene delivery to the spinal cord using MRI-guided focused ultrasound.
Kretz CA, Tomberg K, Van Esbroeck A, Yee A, Ginsburg D
High throughput protease profiling comprehensively defines active site specificity for thrombin and ADAMTS13. Sci Rep. 2018 02 12; 8(1):2788.
High throughput protease profiling comprehensively defines active site specificity for thrombin and ADAMTS13.
Eshel N, Keller CJ, Wu W, Jiang J, Mills-Finnerty C, Huemer J, Wright R, Fonzo GA, Ichikawa N, Carreon D, Wong M, Yee A, Shpigel E, Guo Y, McTeague L, Maron-Katz A, Etkin A
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Global connectivity and local excitability changes underlie antidepressant effects of repetitive transcranial magnetic stimulation. Neuropsychopharmacology. 2020 05; 45(6):1018-1025.
Global connectivity and local excitability changes underlie antidepressant effects of repetitive transcranial magnetic stimulation.
Dengler J, Dolen U, Patterson JMM, Davidge KM, Yee A, Mackinnon SE
Reply: Supercharge End-to-Side Anterior Interosseous-to-Ulnar Motor Nerve Transfer Restores Intrinsic Function in Cubital Tunnel Syndrome. Plast Reconstr Surg. 2022 05 01; 149(5):1042e-1043e.
Reply: Supercharge End-to-Side Anterior Interosseous-to-Ulnar Motor Nerve Transfer Restores Intrinsic Function in Cubital Tunnel Syndrome.
Choksi S, Ballo M, Profant C, Portelli K, Dhar V, Schmidt R, Yee A, Olasky J, Filicori F
Standardizing surgical training with objective performance indicators: a prospective cohort study. Surg Endosc. 2025 04; 39(4):2316-2323.
Standardizing surgical training with objective performance indicators: a prospective cohort study.
Little JS, Medina Pena A, Kim EB, Yee AJ, Nadeem O, Midha S, Sperling AS, Munshi NC, Raje N, Frigault MJ, Cirstea DD, Hammond SP
Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy. Blood Adv. 2025 Aug 26; 9(16):4190-4194.
Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy.
Choksi S, Hirachan B, Ballo M, Winalski J, Jain K, Salas-Parra R, Profant C, Stefanov D, Berniker M, Roslin MS, Dhar V, Yee A, Bessler M, Filicori F
Characterizing advanced stapling technique using objective performance indicators in robotic-assisted sleeve gastrectomy: a retrospective cohort study. Surg Endosc. 2025 Aug; 39(8):4848-4856.
Characterizing advanced stapling technique using objective performance indicators in robotic-assisted sleeve gastrectomy: a retrospective cohort study.
Kanjee Z, Czawlytko CL, Cheung PW, Yee AJ, Ray LJ
Case 30-2025: An 82-Year-Old Woman with Abdominal Distention, Edema, and Pleural Effusion. N Engl J Med. 2025 Oct 23; 393(16):1634-1644.
Case 30-2025: An 82-Year-Old Woman with Abdominal Distention, Edema, and Pleural Effusion.
Patel CG, Yee AJ, Scullen TA, Nemani N, Santo L, Richardson PG, Laubach JP, Ghobrial IM, Schlossman RL, Munshi NC, Anderson KC, Raje NS
Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapy. Clin Cancer Res. 2014 Aug 01; 20(15):3955-61.
Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapy.
Yee AJ, Hari P, Marcheselli R, Mahindra AK, Cirstea DD, Scullen TA, Burke JN, Rodig SJ, Hideshima T, Laubach JP, Ghobrial IM, Schlossman RL, Munshi NC, Anderson KC, Weller EA, Richardson PG, Raje NS
Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomide. Br J Haematol. 2014 Aug; 166(3):401-9.
Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomide.
Cirstea D, Santo L, Hideshima T, Eda H, Mishima Y, Nemani N, Mahindra A, Yee A, Gorgun G, Hu Y, Ohguchi H, Suzuki R, Cottini F, Guichard SM, Anderson KC, Raje N
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myeloma. Mol Cancer Ther. 2014 Nov; 13(11):2489-500.
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myeloma.
Nemani N, Santo L, Eda H, Cirstea D, Mishima Y, Patel C, O'Donnell E, Yee A, Raje N
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Role of decorin in multiple myeloma (MM) bone marrow microenvironment. J Bone Miner Res. 2015 Mar; 30(3):465-70.
Role of decorin in multiple myeloma (MM) bone marrow microenvironment.
Mishima Y, Santo L, Eda H, Cirstea D, Nemani N, Yee AJ, O'Donnell E, Selig MK, Quayle SN, Arastu-Kapur S, Kirk C, Boise LH, Jones SS, Raje N
Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death. Br J Haematol. 2015 May; 169(3):423-34.
Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death.
O'Donnell E, Mahindra A, Yee AJ, Nardi V, Birrer N, Horick N, Borger D, Finkelstein D, Iafrate JA, Raje N
Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple Myeloma. EBioMedicine. 2015 Jan; 2(1):71-3.
Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple Myeloma.
Nakamura K, Bechis MZ, Yee AJ, Dudzinski DM
Progressive Onset of Extracardiac and Myocardial Symptoms: Right Heart Failure and Cor Pulmonale in a Young Man With Debilitating Polyneuropathy and Monoclonal Gammopathy. Circulation. 2015 Jul 07; 132(1):59-67.
Progressive Onset of Extracardiac and Myocardial Symptoms: Right Heart Failure and Cor Pulmonale in a Young Man With Debilitating Polyneuropathy and Monoclonal Gammopathy.
Jurczyszyn A, Olszewska-Szopa M, Hungria V, Crusoe E, Pika T, Delforge M, Leleu X, Rasche L, Nooka AK, Druzd-Sitek A, Walewski J, Davila J, Caers J, Maisnar V, Gertz M, Gentile M, Fantl D, Mele G, Vesole DH, Yee AJ, Shustik C, Lentzsch S, Zweegman S, Gozzetti A, Skotnicki AB, Castillo JJ
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients. Leuk Lymphoma. 2016 09; 57(9):2071-6.
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients.
Lendvai N, Yee AJ, Tsakos I, Alexander A, Devlin SM, Hassoun H, Korde N, Lesokhin AM, Landau H, Mailankody S, Koehne G, Chung DJ, Landgren O, Raje NS, Giralt S
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma. Blood. 2016 05 12; 127(19):2355-6.
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma.
Veld J, O'Donnell EK, Reagan MR, Yee AJ, Torriani M, Rosen CJ, Bredella MA
Abdominal adipose tissue in MGUS and multiple myeloma. Skeletal Radiol. 2016 Sep; 45(9):1277-83.
Abdominal adipose tissue in MGUS and multiple myeloma.
Kretz CA, Dai M, Soylemez O, Yee A, Desch KC, Siemieniak D, Tomberg K, Kondrashov FA, Meng F, Ginsburg D
Massively parallel enzyme kinetics reveals the substrate recognition landscape of the metalloprotease ADAMTS13. Proc Natl Acad Sci U S A. 2015 Jul 28; 112(30):9328-33.
Massively parallel enzyme kinetics reveals the substrate recognition landscape of the metalloprotease ADAMTS13.
Lohr JG, Kim S, Gould J, Knoechel B, Drier Y, Cotton MJ, Gray D, Birrer N, Wong B, Ha G, Zhang CZ, Guo G, Meyerson M, Yee AJ, Boehm JS, Raje N, Golub TR
Genetic interrogation of circulating multiple myeloma cells at single-cell resolution. Sci Transl Med. 2016 11 02; 8(363):363ra147.
Genetic interrogation of circulating multiple myeloma cells at single-cell resolution.
Yee AJ, Bensinger WI, Supko JG, Voorhees PM, Berdeja JG, Richardson PG, Libby EN, Wallace EE, Birrer NE, Burke JN, Tamang DL, Yang M, Jones SS, Wheeler CA, Markelewicz RJ, Raje NS
Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial. Lancet Oncol. 2016 Nov; 17(11):1569-1578.
Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial.
Siu KT, Ramachandran J, Yee AJ, Eda H, Santo L, Panaroni C, Mertz JA, Sims Iii RJ, Cooper MR, Raje N
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma. Leukemia. 2017 08; 31(8):1760-1769.
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma.
Sequencing of nontransplant treatments in multiple myeloma patients with active disease. Hematology Am Soc Hematol Educ Program. 2016 Dec 02; 2016(1):495-503.
Sequencing of nontransplant treatments in multiple myeloma patients with active disease.
Yee AJ, Raz T, Amzallag A, Lipson D, Giladi E, Lopez H, Borger DR, Mino-Kenudson M, Thompson JF, Iafrate AJ, Milos P, Haber DA, Ramaswamy S
Single molecule RNA sequencing of formalin-fixed paraffin-embedded tissue derived from patients with lung cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):10550.
Single molecule RNA sequencing of formalin-fixed paraffin-embedded tissue derived from patients with lung cancer.
Chaly T, Dhawan V, Kazumata K, Antonini A, Margouleff C, Dahl JR, Belakhlef A, Margouleff D, Yee A, Wang S, Tamagnan G, Neumeyer JL, Eidelberg D
Radiosynthesis of [18F] N-3-fluoropropyl-2-beta-carbomethoxy-3-beta-(4-iodophenyl) nortropane and the first human study with positron emission tomography. Nucl Med Biol. 1996 Nov; 23(8):999-1004.
Radiosynthesis of [18F] N-3-fluoropropyl-2-beta-carbomethoxy-3-beta-(4-iodophenyl) nortropane and the first human study with positron emission tomography.
Ristow M, Pfister MF, Yee AJ, Schubert M, Michael L, Zhang CY, Ueki K, Michael MD, Lowell BB, Kahn CR
Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. Proc Natl Acad Sci U S A. 2000 Oct 24; 97(22):12239-43.
Frataxin activates mitochondrial energy conversion and oxidative phosphorylation.
Dey BR, Shaffer J, Yee AJ, McAfee S, Caron M, Power K, Ting DT, Colby C, Preffer F, Ballen K, Attar E, Saidman S, Tarbell N, Sachs D, Sykes M, Spitzer TR
Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen. Bone Marrow Transplant. 2007 Jul; 40(1):19-27.
Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen.
Skvorak AB, Weng Z, Yee AJ, Robertson NG, Morton CC
Human cochlear expressed sequence tags provide insight into cochlear gene expression and identify candidate genes for deafness. Hum Mol Genet. 1999 Mar; 8(3):439-52.
Human cochlear expressed sequence tags provide insight into cochlear gene expression and identify candidate genes for deafness.
Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients. Clin Interv Aging. 2012; 7:331-8.
Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients.
Myeloma and Bone Disease. Curr Osteoporos Rep. 2017 10; 15(5):483-498.
Successful recovery after an overdose of argatroban. Ann Pharmacother. 2006 Feb; 40(2):336-9.
Successful recovery after an overdose of argatroban.
Wang Y, Yee AJ, Sirard C, Landau S, Raje N, Mahmood U
Sodium fluoride PET imaging as a quantitative pharmacodynamic biomarker for bone homeostasis during anti-DKK1 therapy for multiple myeloma. Blood Cancer J. 2017 10 06; 7(10):e615.
Sodium fluoride PET imaging as a quantitative pharmacodynamic biomarker for bone homeostasis during anti-DKK1 therapy for multiple myeloma.
Denosumab for the treatment of bone disease in solid tumors and multiple myeloma. Future Oncol. 2018 Feb; 14(3):195-203.
Denosumab for the treatment of bone disease in solid tumors and multiple myeloma.
Jurczyszyn A, Radocha J, Davila J, Fiala MA, Gozzetti A, Grzasko N, Robak P, Hus I, Waszczuk-Gajda A, Guzicka-Kazimierczak R, Atilla E, Mele G, Sawicki W, Jayabalan DS, Charlinski G, Szabo AG, Hajek R, Delforge M, Kopacz A, Fantl D, Waage A, Avivi I, Rodzaj M, Leleu X, Richez V, Knopinska-Posluszny W, Masternak A, Yee AJ, Barchnicka A, Druzd-Sitek A, Guerrero-Garcia T, Liu J, Vesole DH, Castillo JJ
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients. Br J Haematol. 2018 03; 180(6):831-839.
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients.
Magill CK, Moore AM, Yan Y, Tong AY, MacEwan MR, Yee A, Hayashi A, Hunter DA, Ray WZ, Johnson PJ, Parsadanian A, Myckatyn TM, Mackinnon SE
The differential effects of pathway- versus target-derived glial cell line-derived neurotrophic factor on peripheral nerve regeneration. J Neurosurg. 2010 Jul; 113(1):102-9.
The differential effects of pathway- versus target-derived glial cell line-derived neurotrophic factor on peripheral nerve regeneration.
Vogl DT, Dingli D, Cornell RF, Huff CA, Jagannath S, Bhutani D, Zonder J, Baz R, Nooka A, Richter J, Cole C, Vij R, Jakubowiak A, Abonour R, Schiller G, Parker TL, Costa LJ, Kaminetzky D, Hoffman JE, Yee AJ, Chari A, Siegel D, Fonseca R, Van Wier S, Ahmann G, Lopez I, Kauffman M, Shacham S, Saint-Martin JR, Picklesimer CD, Choe-Juliak C, Stewart AK
Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma. J Clin Oncol. 2018 03 20; 36(9):859-866.
Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma.
Davidge KM, Yee A, Kahn LC, Mackinnon SE
Median to radial nerve transfers for restoration of wrist, finger, and thumb extension. J Hand Surg Am. 2013 Sep; 38(9):1812-27.
Median to radial nerve transfers for restoration of wrist, finger, and thumb extension.
Double fascicular nerve transfer to the biceps and brachialis muscles after brachial plexus injury: clinical outcomes in a series of 29 cases. J Neurosurg. 2011 Jun; 114(6):1520-8.
Double fascicular nerve transfer to the biceps and brachialis muscles after brachial plexus injury: clinical outcomes in a series of 29 cases.
Nerve transfers for the restoration of hand function after spinal cord injury. J Neurosurg. 2012 Jul; 117(1):176-85.
Nerve transfers for the restoration of hand function after spinal cord injury.
Nerve transfer to the triceps after brachial plexus injury: report of four cases. J Hand Surg Am. 2011 Mar; 36(3):398-405.
Nerve transfer to the triceps after brachial plexus injury: report of four cases.
Whitlock EL, Myckatyn TM, Tong AY, Yee A, Yan Y, Magill CK, Johnson PJ, Mackinnon SE
Dynamic quantification of host Schwann cell migration into peripheral nerve allografts. Exp Neurol. 2010 Oct; 225(2):310-9.
Dynamic quantification of host Schwann cell migration into peripheral nerve allografts.
Sung HJ, Eskin SG, Sakurai Y, Yee A, Kataoka N, McIntire LV
Oxidative stress produced with cell migration increases synthetic phenotype of vascular smooth muscle cells. Ann Biomed Eng. 2005 Nov; 33(11):1546-54.
Oxidative stress produced with cell migration increases synthetic phenotype of vascular smooth muscle cells.
American journal of physiology. Cell physiology
Cyclic strain and motion control produce opposite oxidative responses in two human endothelial cell types. Am J Physiol Cell Physiol. 2007 Jul; 293(1):C87-94.
Cyclic strain and motion control produce opposite oxidative responses in two human endothelial cell types.
Ray WZ, Pet MA, Nicoson MC, Yee A, Kahn LC, Mackinnon SE
Two-level motor nerve transfer for the treatment of long thoracic nerve palsy. J Neurosurg. 2011 Oct; 115(4):858-64.
Two-level motor nerve transfer for the treatment of long thoracic nerve palsy.
Distal median to ulnar nerve transfers to restore ulnar motor and sensory function within the hand: technical nuances. Neurosurgery. 2009 Nov; 65(5):966-77; discussion 977-8.
Distal median to ulnar nerve transfers to restore ulnar motor and sensory function within the hand: technical nuances.
Ray WZ, Yarbrough CK, Yee A, Mackinnon SE
Clinical outcomes following brachialis to anterior interosseous nerve transfers. J Neurosurg. 2012 Sep; 117(3):604-9.
Clinical outcomes following brachialis to anterior interosseous nerve transfers.
Davidge KM, Yee A, Moore AM, Mackinnon SE
The Supercharge End-to-Side Anterior Interosseous-to-Ulnar Motor Nerve Transfer for Restoring Intrinsic Function: Clinical Experience. Plast Reconstr Surg. 2015 Sep; 136(3):344e-352e.
The Supercharge End-to-Side Anterior Interosseous-to-Ulnar Motor Nerve Transfer for Restoring Intrinsic Function: Clinical Experience.
Davidge KM, Gontre G, Tang D, Boyd KU, Yee A, Damiano MS, Mackinnon SE
The "hierarchical" Scratch Collapse Test for identifying multilevel ulnar nerve compression. Hand (N Y). 2015 Sep; 10(3):388-95.
The "hierarchical" Scratch Collapse Test for identifying multilevel ulnar nerve compression.
Brown JM, Yee A, Ivens RA, Dribben W, Mackinnon SE
Post-cervical decompression parsonage-turner syndrome represents a subset of C5 palsy: six cases and a review of the literature: case report. Neurosurgery. 2010 Dec; 67(6):E1831-43; discussion E1843-4.
Post-cervical decompression parsonage-turner syndrome represents a subset of C5 palsy: six cases and a review of the literature: case report.
Functional display of platelet-binding VWF fragments on filamentous bacteriophage. PLoS One. 2013; 8(9):e73518.
Functional display of platelet-binding VWF fragments on filamentous bacteriophage.
Magill CK, Tuffaha SH, Yee A, Luciano JP, Hunter DA, Mackinnon SE, Borschel GH
The short- and long-term effects of Seprafilm on peripheral nerves: a histological and functional study. J Reconstr Microsurg. 2009 Jul; 25(6):345-54.
The short- and long-term effects of Seprafilm on peripheral nerves: a histological and functional study.
Supercharged end-to-side anterior interosseous to ulnar motor nerve transfer for intrinsic musculature reinnervation. J Hand Surg Am. 2012 Oct; 37(10):2150-9.
Supercharged end-to-side anterior interosseous to ulnar motor nerve transfer for intrinsic musculature reinnervation.
Von Willebrand factor: form for function. Semin Thromb Hemost. 2014 Feb; 40(1):17-27.
Von Willebrand factor: form for function.
Tang DT, Barbour JR, Davidge KM, Yee A, Mackinnon SE
Nerve entrapment: update. Plast Reconstr Surg. 2015 Jan; 135(1):199e-215e.
Yee A, Bosworth KA, Conway DE, Eskin SG, McIntire LV
Gene expression of endothelial cells under pulsatile non-reversing vs. steady shear stress; comparison of nitric oxide production. Ann Biomed Eng. 2008 Apr; 36(4):571-9.
Gene expression of endothelial cells under pulsatile non-reversing vs. steady shear stress; comparison of nitric oxide production.
Turcotte LP, Swenberger JR, Zavitz Tucker M, Yee AJ
Increased fatty acid uptake and altered fatty acid metabolism in insulin-resistant muscle of obese Zucker rats. Diabetes. 2001 Jun; 50(6):1389-96.
Increased fatty acid uptake and altered fatty acid metabolism in insulin-resistant muscle of obese Zucker rats.
Phillips BZ, Franco MJ, Yee A, Tung TH, Mackinnon SE, Fox IK
Direct radial to ulnar nerve transfer to restore intrinsic muscle function in combined proximal median and ulnar nerve injury: case report and surgical technique. J Hand Surg Am. 2014 Jul; 39(7):1358-62.
Direct radial to ulnar nerve transfer to restore intrinsic muscle function in combined proximal median and ulnar nerve injury: case report and surgical technique.
Kale SS, Glaus SW, Yee A, Nicoson MC, Hunter DA, Mackinnon SE, Johnson PJ
Reverse end-to-side nerve transfer: from animal model to clinical use. J Hand Surg Am. 2011 Oct; 36(10):1631-1639.e2.
Reverse end-to-side nerve transfer: from animal model to clinical use.
Ray WZ, Kasukurthi R, Papp EM, Moore AM, Yee A, Hunter DA, Solowski NL, Mohanakumar T, Mackinnon SE, Tung TH
The role of T helper cell differentiation in promoting nerve allograft survival with costimulation blockade. J Neurosurg. 2010 Feb; 112(2):386-93.
The role of T helper cell differentiation in promoting nerve allograft survival with costimulation blockade.
Curvature is a basic feature for visual search tasks. Perception. 1992; 21(4):465-80.
Curvature is a basic feature for visual search tasks.